Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epstein-Barr Virus-Related Lymphoma | Preclinical | United States | 01 Jul 2018 |